smart. precise. brilliant.
Eyenovia is a clinical stage, ophthalmic biopharmaceutical company transforming the delivery of therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. Eyenovia’s breakthrough piezo-dispersion and microdosing technology enable a portfolio of first-in-class, next-generation, micro-therapeutics for the eye designed to reduce ocular and systemic toxicity and improve the risk-benefit profile of both new and existing therapeutics.
At Eyenovia, we believe that when it comes to your eyes, smaller is better.
Eyenovia: Changing the 100-year old
eyedropper paradigm. Microdrops reduce conventional
overdosing by more than 80%!
Eyenovia: High precision targeted
microdroplet therapy …precEYEsely.
Beat the blink! Eyenovia microdrops are delivered
within 80 milliseconds…Faster than the blink reflex!
“Smart eye care...means better eye care! Dynamic, real time monitoring and compliance data for you and your doctor!
Watch a brief video about our technology
TEST YOUR EYE Q
Eyenovia’s development pipeline includes three late stage NDA-enabling programs in key ophthalmic indications
Contact us for more information
Contact us today to learn more about how our microdosing technology is poised to transform the standard of care in ophthalmic therapeutic delivery.
295 Madison Avenue, Suite 2400 NY, NY 10017 [email protected]